STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
Reported by STAT News · all stories from statnews.com
Editorial digest
The leader of the FDA's digital health division has announced that regulatory guidance for generative artificial intelligence tools is forthcoming. This will clarify how the agency plans to oversee this rapidly advancing technology.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/18/2026
FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices | AHA News - American Hospital Association
The FDA seeks input on regulating generative AI for medical devices.
- Trusted health newsroom8/19/2026
FDA seeks feedback on generative AI regulations - MedTech Dive
The FDA is soliciting public input on regulating generative AI technologies.
- Trusted health newsroom8/20/2026
FDA weighs regulatory approach for genAI medical devices - MobiHealthNews
The FDA is deliberating its regulatory strategy for generative AI medical devices.
- Trusted health newsroom8/14/2026
STAT+: Epic’s alleged anticompetitive practices under scrutiny from federal, state investigators
Epic's alleged anticompetitive actions are under federal and state investigation.
- Official source7/23/2026
Digital Health Technologies (DHTs) for Drug Development - fda.gov
The FDA issued guidance on Digital Health Technologies for drug development.
- Reputable trade press8/19/2026
FDA Opens Comment Period on GenAI Device Regulation - Medical Device and Diagnostic industry
The FDA is seeking public comments on generative AI regulation in medical devices.